Who is the CEO of OceansBio?

According to the DART company overview, OceansBio's representative director is 이현웅 (name as registered in Korean). The company was founded on 2018-07-20.

Where is OceansBio listed?

OceansBio trades on the Korea Exchange KONEX market under the ticker 332190. Its fiscal year ends in December.

Does OceansBio pay a dividend?

OceansBio did not pay a cash dividend for fiscal 2025, according to its annual report.

Does OceansBio have any recent filing signals?

Signals detected automatically from DART filings and quarterly results: Dilution risk (rights offering or CB/BW/EB issue decided in the past 90 days); Private placement (third-party allotment rights offering decided in the past 90 days). These are factual flags, not investment advice.

Which companies are in the same industry as OceansBio?

Under the Korean Standard Industrial Classification recorded on DART, OceansBio is grouped with 27 other listed companies in medical devices. The most covered in Korean news over the past 30 days are Seers, Sky Labs and Medyssey.

OceansBio KRX:332190KONEX

오션스바이오 · Korean news coverage and regulatory filings, organized.

한국어

Articles, 24h0

Articles, 7 days0

DART filings, 7 days0

Articles tracked4since Sep 11

OceansBio (오션스바이오) appeared in 0 Korean news articles and 0 DART filings over the past seven days. Coverage peaked on Oct 22 with 2 articles.

Filing signals Private placement Dilution risk Screener

OceansBio top stories 2 weeks, by number of outlets

1
오션스바이오, 시노팜 윈난과 중국 전자약 사업 협력 MOU
1 outlets · 1 articlesFirst report Oct 22 08:42 메디포뉴스
2
전자약·웰니스 제품 중국 진출…오션스바이오, 현지 교두보 확보
1 outlets · 1 articlesFirst report Oct 22 17:30 머니투데이

Latest OceansBio news Korean headlines

Oct 2217:30

전자약·웰니스 제품 중국 진출…오션스바이오, 현지 교두보 확보
머니투데이
Oct 2208:42

오션스바이오, 시노팜 윈난과 중국 전자약 사업 협력 MOU
메디포뉴스
Sep 2422:06

디캠프·한국무라타전자, K-딥테크 9곳 일본 기술과 연결…리피즈·오션스바이오 우수기업
벤처스퀘어
Sep 2311:03

리피즈 로보틱스-오션스바이오, 디캠프-한국무라타전자 개최 ‘프라이빗 피칭’ 우수기업 선정
와우테일

Articles per day 2 weeks

222

Company profile

CEO: 이현웅
Industry: Medical devices
Founded: 2018-07-20
Fiscal year-end: December
Head office: 경상남도 창원시
Website: oceansbio.com
Quotes & chart: Naver Securities (Korean)

From the DART company overview.

Same industry Medical devices

All in industry

Company	Latest quarter op. profit	Articles 30d
Seers	₩12.9bn	76
Sky Labs	–	71
Medyssey	–	47
InBody	₩17.7bn	29
Cosmo Robotics	−₩3.3bn	24
Finemedix	₩790m	23
Dynamic solution	−₩950m	20
Hironic	₩1.1bn	19

Compare OceansBio side by side with these companies

OceansBio DART filings

Oct 2217:03

Other 증권발행결과(자율공시) (제3자배정 유상증자)
Other
Oct 1416:43

Rights offering 주요사항보고서(유상증자결정)
Capital & M&A
Oct 616:19

Investor relations event 기업설명회(IR)개최결과
Other
Sep 1813:10

Investor relations event 기업설명회(IR)개최
Other

Mentioned alongside 2 weeks

No co-mentioned companies yet.

OceansBio FAQ

Who is the CEO of OceansBio?: According to the DART company overview, OceansBio's representative director is 이현웅 (name as registered in Korean). The company was founded on 2018-07-20.
Where is OceansBio listed?: OceansBio trades on the Korea Exchange KONEX market under the ticker 332190. Its fiscal year ends in December.
Does OceansBio pay a dividend?: OceansBio did not pay a cash dividend for fiscal 2025, according to its annual report.
Does OceansBio have any recent filing signals?: Signals detected automatically from DART filings and quarterly results: Dilution risk (rights offering or CB/BW/EB issue decided in the past 90 days); Private placement (third-party allotment rights offering decided in the past 90 days). These are factual flags, not investment advice.
Which companies are in the same industry as OceansBio?: Under the Korean Standard Industrial Classification recorded on DART, OceansBio is grouped with 27 other listed companies in medical devices. The most covered in Korean news over the past 30 days are Seers, Sky Labs and Medyssey.